One-year follow-up evaluation of 260 premature infants with respiratory distress syndrome and birth weights of 700 to 1350 grams randomized to two rescue doses of synthetic surfactant or air placebo

[1]  R. Sauve,et al.  Double-blind 1-year follow-up of 1540 infants with respiratory distress syndrome randomized to rescue treatment with two doses of synthetic surfactant or air in four clinical trials. American and Canadian Exosurf Neonatal Study Groups. , 1995, The Journal of pediatrics.

[2]  R. Soll,et al.  Clinical trials of natural surfactant extract in respiratory distress syndrome. , 1993, Clinics in perinatology.

[3]  R. Soll,et al.  Overview of Exogenous Surfactant Replacement Therapy , 1993 .

[4]  J. Horbar,et al.  Decreasing mortality associated with the introduction of surfactant therapy: an observational study of neonates weighing 601 to 1300 grams at birth. The Members of the National Institute of Child Health and Human Development Neonatal Research Network. , 1993, Pediatrics.

[5]  A. Jobe,et al.  Pulmonary surfactant therapy. , 1993, The New England journal of medicine.

[6]  R. Good.  Mixed chimerism and immunologic tolerance. , 1993, The New England journal of medicine.

[7]  R. Cotton,et al.  A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group. , 1991 .

[8]  W. Long,et al.  Reduced mortality in small premature infants treated at birth with a single dose of synthetic surfactant , 1991, Journal of paediatrics and child health.

[9]  D. Heilbron,et al.  Initial clinical trial of EXOSURF, a protein-free synthetic surfactant, for the prophylaxis and early treatment of hyaline membrane disease. , 1991, Pediatrics.

[10]  J. Gilhooly,et al.  Reduction of neonatal mortality after multiple doses of bovine surfactant in low birth weight neonates with respiratory distress syndrome. , 1991, Pediatrics.

[11]  S. Goldman,et al.  Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: a multicenter controlled trial. American Exosurf Pediatric Study Group 1. , 1991, The Journal of pediatrics.

[12]  C. Morley,et al.  Follow up of premature babies treated with artificial surfactant (ALEC). , 1990, Archives of disease in childhood.

[13]  M. McCormick,et al.  Health and developmental outcomes of a surfactant controlled trial: follow-up at 2 years. , 1990, Pediatrics.

[14]  G. Enhorning,et al.  Two-year follow-up of infants enrolled in a randomized trial of surfactant replacement therapy for prevention of neonatal respiratory distress syndrome. , 1988, Pediatrics.

[15]  Y. Vaucher,et al.  Neurodevelopmental and respiratory outcome in early childhood after human surfactant treatment. , 1988, American journal of diseases of children.

[16]  H. Halliday,et al.  Growth and development two years after artificial surfactant replacement at birth. , 1986, Early human development.

[17]  R. Bejar,et al.  Outcome at twelve months of adjusted age in very low birth weight infants with lung immaturity: a randomized, placebo-controlled trial of human surfactant. , 1993, The Journal of pediatrics.